Year
2026
Organisation
Summary
Myasthenia gravis is a rare autoimmune disease disrupting communication between nerves and muscles. Analysis of 36 years of national data shows diagnoses are increasing and mortality risk is highest in the first year after diagnosis. Earlier recognition and intervention could improve outcomes by identifying critical periods when treatment is most effective.